Dilapro contains the active substance carvedilol, which causes unselective blockade of beta-1 and beta-2 receptors and selective blockade of alpha-1 receptors in heart and vascular system.
Dilapro is used in:
• treatment of stable, symptomatic, chronic heart failure of all degrees of severity, of ischemic or non-ischemic origin – in combination with standard therapy (such as ACE inhibitors and diuretics, with or without digitalis), if there is no contraindication.